Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies
Portfolio Pulse from
Teknova and Pluristyx have launched the PluriFreeze™ cryopreservation system, which is now available exclusively through Teknova. This product aims to accelerate the development of cell therapies.
March 19, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Teknova has partnered with Pluristyx to launch the PluriFreeze™ cryopreservation system, which is expected to enhance the development of cell therapies. This exclusive distribution could strengthen Teknova's market position in the biotech sector.
The launch of the PluriFreeze™ system, exclusively distributed by Teknova, is likely to positively impact Teknova's stock. This partnership and product offering could enhance Teknova's reputation and market share in the biotech industry, particularly in the cell therapy sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90